Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28151236 | 1.00 | ALDH1A1 (0.33) | — | |
| Hydrochloric Acid SCHEMBL28743568 | 1.00 | ALDH1A1 (0.33) | — | |
| Hydrochloric Acid SCHEMBL5325738 | 0.95 | ALDH1A1 (0.36) | — | |
| Hydrochloric Acid SCHEMBL3521843 | 0.95 | — | — | |
| Ammonia Solution, Strong SCHEMBL28460951 | 0.95 | ALDH1A1 (0.36) | — | |
| Hydrochloric Acid SCHEMBL844 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL10651080 | 0.95 | ALDH1A1 (0.36) | — | |
| Hydrochloric Acid SCHEMBL8812637 | 0.95 | ALDH1A1 (0.36) | — | |
| Hydrochloric Acid SCHEMBL7930062 | 0.95 | ALDH1A1 (0.36) | — | |
| Hydrochloric Acid SCHEMBL5047658 | 0.95 | ALDH1A1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113522052-B | Composite hollow fiber membrane and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2024-07-16 | — | — | CN | claimed |
| CN-106946929-A | Three（Trimethyl silicon substrate）Phosphate synthesis method | 石家庄圣泰化工有限公司 | 2017-07-14 | — | — | CN | claimed |
| EP-4694995-A1 | A CHROMATOGRAPHY MATERIAL, USE THEREOF, AND A METHOD FOR SEPARATING ADENO-ASSOCIATED CAPSIDS | Cytiva BioProcess R&D AB (SE) | 2026-02-18 | — | — | EP | disclosed |
| WO-2024213492-A1 | A CHROMATOGRAPHY MATERIAL, USE THEREOF, AND A METHOD FOR SEPARATING ADENO-ASSOCIATED CAPSIDS | CYTIVA BIOPROCESS R&D AB (SE) | 2024-10-17 | — | — | WO | disclosed |
| CN-113522052-B | Composite hollow fiber membrane and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2024-07-16 | — | — | CN | disclosed |
| CN-109867608-A | A kind of process for cleanly preparing of glycine co-producing potassium chloride | 刘长飞 | 2019-06-11 | — | — | CN | disclosed |
| CN-109836344-A | A kind of method of organic solvent production glycine | 刘长飞 | 2019-06-04 | — | — | CN | disclosed |
| CN-108203390-A | A kind of method using organic solvent production glycine | 青岛祥智电子技术有限公司 | 2018-06-26 | — | — | CN | disclosed |
| CN-107868017-A | A kind of method that glycine is produced using organic solvent | 青岛九洲千和机械有限公司 | 2018-04-03 | — | — | CN | disclosed |
| CN-102149280-B | Deuterated benzylbenzene derivatives and methods of use thereof | 泰拉科斯有限公司 | 2017-05-24 | — | — | CN | disclosed |
| CN-106699591-A | Clean production process of glycine and co-produced ammonium chloride | 青岛森美克化工技术有限公司 | 2017-05-24 | — | — | CN | disclosed |
| US-7629338-B2 | Substituted monocyclic CGRP receptor antagonists | MERCK & CO., INC. (US) | 2009-12-08 | — | — | US | disclosed |
| US-7625901-B2 | Substituted monocyclic CGRP receptor antagonists | MERCK & CO., INC. (US) | 2009-12-01 | — | — | US | disclosed |
| EP-2029575-A1 | SUBSTITUTED SPIROCYCLIC CGRP RECEPTOR ANTAGONISTS | Merck & Co., Inc. (US) | 2009-03-04 | — | — | EP | disclosed |
| US-20080318927-A1 | Substituted monocyclic CGRP receptor antagonists | MERCK SHARP & DOHME LLC | 2008-12-25 | — | — | US | disclosed |
| WO-2008020902-A1 | SUBSTITUTED SPIROCYCLIC CGRP RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2008-02-21 | — | — | WO | disclosed |
| US-20070265225-A1 | Substituted monocyclic CGRP receptor antagonists | MERCK SHARP & DOHME LLC | 2007-11-15 | — | — | US | disclosed |
| CN-1880305-A | Production method of n-(cyclohixylthio) phthalimide | TORAY FINECHEMICALS CO LTD (JP) | 2006-12-20 | — | — | CN | disclosed |
| CN-1195738-C | 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds | AVENTIS PHARMA GMBH (DE) | 2005-04-06 | — | — | CN | disclosed |
| CN-1373750-A | 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds | AVENTIS PHARMA GMBH (DE) | 2002-10-09 | — | — | CN | disclosed |